COPD News Today

June 30, 2020July 1, 2020

Breztri Aerosphere Leads to Lower COPD Exacerbation Rate Compared With Dual Therapies, Trial Shows

COPD News Today

Breztri Aerosphere, AstraZeneca’s triple combination therapy for chronic obstructive pulmonary disease (COPD), significantly reduces the frequency of moderate or severe exacerbations, compared to dual combination therapies, in patients with moderate ... Read more

June 25, 2020June 26, 2020

Vitamin D Deficiency Linked to Lung Function Decline, Exacerbations, Study Finds 

COPD News Today

A vitamin D deficiency in people with chronic obstructive pulmonary disease (COPD) is associated with a decline in lung function, and with increased odds of acute exacerbations, a large-scale analysis ... Read more

June 23, 2020June 24, 2020

Pulmonary Rehabilitation Within 3 Months of Hospital Stay Improves Survival

COPD News Today

Starting a pulmonary rehabilitation program within three months of hospitalization for chronic obstructive pulmonary disease, or COPD, improved the rate of survival over one year by 6.7%, according to new ... Read more

June 18, 2020June 19, 2020

Undersized Airways May Explain Why Some Nonsmokers Develop COPD

COPD News Today

Having small airways compared to lung size may contribute to the development of chronic obstructive pulmonary disease (COPD) in many non-smokers, a retrospective study has found. The finding broadens understanding of the ... Read more

June 16, 2020June 17, 2020

Lung Denervation System Named FDA Breakthrough Device

COPD News Today

Nuvaira‘s Lung Denervation System, under clinical investigation for its use in treating chronic obstructive pulmonary disease (COPD), has been designated a breakthrough device by the U.S. Food and Drug Administration ... Read more

June 11, 2020June 11, 2020

MUSC Resumes Clinical Trial Testing Targeted Lung Denervation

COPD News Today

Following a stop due to the COVID-19 pandemic, the Medical University of South Carolina (MUSC) has become the first medical center to restart the AIRFLOW-3 clinical trial, which is testing ... Read more

June 9, 2020June 10, 2020

Lung Patients’ Improvement Amid UK Lockdown Spurs Call to Reduce Air Pollution

COPD News Today

As air pollution levels fall in the wake of widespread lockdowns due to the COVID-19 pandemic, one in six U.K. residents with lung conditions report improving symptoms. More than half ... Read more

June 4, 2020June 5, 2020

Stem Cell Therapy Benefits Patients with Severe Inflammation, Trial Data Show

COPD News Today

Remestemcel-L, Mesoblast’s lead candidate stem cell therapy for inflammatory diseases, improves lung function and exercise capacity in people with chronic obstructive pulmonary disease (COPD) and a high degree of inflammation, data ... Read more

June 3, 2020

COVID-19: Your Weekly Roundup of Key Developments

COPD News Today, COVID-19 News

Early results show potential benefits of remdesivir Gilead announced top-line results from its Phase 3 SIMPLE clinical trial (NCT04292899) testing the safety and antiviral activity of remdesivir. According to the ... Read more

June 2, 2020June 3, 2020

COPD, Smoking Increase Death Risk in COVID-19 Patients, Study Says

COPD News Today, COVID-19 News

Smokers and people with chronic obstructive pulmonary disease (COPD) are more likely to develop severe complications and die from COVID-19 infections than infected patients who do not smoke or have COPD, ... Read more

May 28, 2020May 29, 2020

Overweight COPD Patients at Greater Risk of Contracting COVID-19, Study Suggests

COPD News Today, COVID-19 News

People with chronic obstructive pulmonary disease (COPD) who are overweight have increased levels of the protein that the SARS-CoV-2 virus — the virus that causes COVID-19 — uses to get into ... Read more

May 21, 2020May 22, 2020

COPD Seen to Raise Risk of Lung Cancer in Non-smokers

COPD News Today

Chronic obstructive pulmonary disease (COPD) is linked to a higher risk of lung cancer in people who never smoked. In fact, their risk is equivalent to current or former smokers ... Read more

May 14, 2020May 14, 2020

Zephyr Valve Eases Breathlessness in Severe Emphysema, Trial Analysis Shows

COPD News Today

Pulmonx’s  Zephyr Endobronchial Valve significantly reduces breathlessness and improves physical activity and quality of life in people with severe emphysema, a post-hoc analysis of clinical trial data shows. The study, ... Read more

May 7, 2020May 7, 2020

Expansion of Unusual Stem Cell Subsets May Drive COPD Progression, Study Suggests

COPD News Today

People with chronic obstructive pulmonary disease (COPD) have three unusual stem cell subsets in their lungs that, together, seem to contribute to the inflammation, tissue scarring, and excessive mucus secretion ... Read more

April 30, 2020April 30, 2020

Triple Combo Therapy Reduces All-cause Mortality in COPD, Analysis Suggests

COPD News Today

Triple therapy with fluticasone furoate (FF), umeclidinium (UMEC), and vilanterol (VI) can reduce mortality rates among people with chronic obstructive pulmonary disease (COPD) more than VI treatment with either FF ... Read more